Skip to main content
Caplight Logo









SkinVision

SkinVision

Private
AmsterdamHealthcare & Life Scienceshttps://www.skinvision.com/

Last Round

Debt

Apr 1, 2026

Total Funding Raised

$11M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

SkinVision is a health-tech company that provides a mobile application using AI-powered technology to help users perform self-checks for skin cancer.

Sector

Healthcare & Life Sciences

Verticals

InsurTech, Medical AI, Telemedicine, Medical Devices

Business Model

B2B2C

Customer Profile

Subscription SaaS, Freemium, Usage-Based SaaS

AI Layer

Application

Keywords

skin cancer detectionmedical AImole checker appskin checker appteledermatologydigital health appCE-certified medical deviceearly detectionrisk assessmentcomputer visionhealth insurance benefitemployee wellnessB2B2CInsurTech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SkinVision Comparables

Compare SkinVision with similar companies based on industry and business-model similarity.

SkinVision comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
medaia GmbH
85%
Miiskin
81%
SkinIO
81%

SkinVision Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtApr 1, 2026
VC RoundOct 1, 2020
Series AJul 30, 2018
VC RoundMar 8, 2017
SeedAug 20, 2015

Key People

Founding team and executive leadership

Andreas Vitsentzatos

Chief Operating Officer

Executive Team

SkinVision Investors

Notable investors and investment history

SkinVision investors
InvestorRounds
LEO Innovation LabVC Round
Rubio Impact VenturesVC Round
Personal Health Solutions (PHS) CapitalSeed, VC Round, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    $3.5M debt round led by Rabobank.

  • Jan 13, 2026

    Operations include Pipedrive, Looker, Zendesk, Jira, and Confluence.

Recent news

Latest coverage and updates

  • launchesJun 16, 2026

    SkinVision launched SkinVision Pro at HLTH Europe on Jun 16th '26.

SkinVision Filings

Explore SEC and related filing metadata, where available.

SkinVision filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SkinVision's valuation, stock price, and market status.

Is SkinVision a public or private company?

SkinVision is a private company.

What is the current stock price of SkinVision?

SkinVision is a private company with no public stock price. No recent secondary market data is available.

How much is SkinVision worth (valuation)?

Valuation information for SkinVision is not publicly available.

Can I buy SkinVision stock?

SkinVision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SkinVision's last funding round?

SkinVision's most recent funding round was VC Round on July 30, 2018.

Who are the main investors in SkinVision?

Key investors in SkinVision include LEO Innovation Lab.

Will SkinVision IPO soon?

No public IPO plans have been announced for SkinVision.

How can I track SkinVision secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SkinVision's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAmsterdam
Employee Range63
Year Founded2011
Last FundingApr 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?